|
Successful commercialization of
health technology requires quality innovation plus experienced
management, market and technical expertise, and access to sufficient
capital. These elements represent the gap between innovation
& commercialization …without them the potential is
never realized.
Genesys Venture Inc. (GVI) provides the expertise, experience and energy required to
start-up and manage emerging health and biotechnology ventures. Founded by renowned
bio-entrepreneur Dr. Albert D. Friesen, the GVI team has
extensive experience in technology and business development to offer its clients.
The Company provides many services to client companies through
an enhanced incubation model and active participation. GVI takes the idea of an incubator
to the next level, becoming actively involved with each new venture and offering a
tailored mix of services vital to successfully develop a technology to address market
opportunities.
GVI believes that entrepreneurs on the leading edge of new and innovative technologies can
benefit from a location that complies with all the high standards needed for the industry.
To that end, GVI is situated in a newly constructed facility that houses both research and
management staff of GVI and several client companies. The custom
designed building provides access to business structure and state of the art equipment. In
addition, GVI is capable of providing incubation to companies located wherever their
R&D needs are suited.
A proven track record and an experienced and talented team make
Genesys Venture Inc. a unique vehicle for developing innovative
ventures. GVI’s established reputation and strong relationships
within the life science and financial community assist in identifying
strategic partners and building value through the product development
process...this approach has resulted in zero failures.
GVI is co-owned by the Manitoba Science & Technology
Fund, a venture capital fund dedicated to growth of this sector
within Manitoba. GVI and its clients also benefit from a strong
relationship with the University of Manitoba and all three
levels of government.
GVI has a referral and cooperation agreement with CentreStone
Ventures Fund. CentreStone
Ventures is a life sciences focused private venture capital
fund investing primarily in early stage therapeutics, medical
device, diagnostic and drug delivery companies.
|
|
